Potential pitfalls of reproductive direct-to-consumer testing.

Direct-to-consumer testing fertility diagnostic testing laboratory methodology ovarian reserve testing

Journal

F&S reports
ISSN: 2666-3341
Titre abrégé: F S Rep
Pays: United States
ID NLM: 101766618

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 01 11 2021
revised: 25 01 2022
accepted: 26 01 2022
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 8 4 2022
Statut: epublish

Résumé

The availability of direct-to-consumer (DTC) testing has dramatically increased over the past 2 decades, particularly those targeted at reproduction and fertility. Several ethical concerns exist with regard to DTC tests, including the lack of governmental regulation and consumer protection, standardized laboratory methodology, and clinical validity and actionability. Physicians must familiarize themselves with the pitfalls of DTC tests to best aid patients in interpreting DTC test results and guide them toward evidence-based treatment plans.

Identifiants

pubmed: 35386504
doi: 10.1016/j.xfre.2022.01.007
pii: S2666-3341(22)00008-3
pmc: PMC8978065
doi:

Types de publication

Journal Article

Langues

eng

Pagination

3-7

Informations de copyright

© 2022 Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine.

Références

Obstet Gynecol. 2015 Jan;125(1):268-273
pubmed: 25560143
Fertil Steril. 2021 Jul;116(1):36-47
pubmed: 34148587
BMC Med. 2016 Oct 3;14(1):151
pubmed: 27716302
J Assist Reprod Genet. 2000 Sep;17(8):457-9
pubmed: 11062858
JAMA. 2017 Sep 26;318(12):1150-1160
pubmed: 28973622
JAMA. 2017 Oct 10;318(14):1367-1376
pubmed: 29049585
Hum Reprod. 2014 May;29(5):1042-8
pubmed: 24626805
Fertil Steril. 2016 Apr;105(4):1063-1069.e3
pubmed: 26769302
Fertil Steril. 2012 Dec;98(6):1602-8.e2
pubmed: 22959460
Reprod Biol Endocrinol. 2020 Aug 15;18(1):86
pubmed: 32799874
Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1713-9
pubmed: 17855686
Front Endocrinol (Lausanne). 2021 May 24;12:691432
pubmed: 34108942
Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):903-6
pubmed: 20332268
Fertil Steril. 2020 Dec;114(6):1151-1157
pubmed: 33280722
Cancer. 2019 Jan 1;125(1):12-14
pubmed: 30387874
Front Endocrinol (Lausanne). 2021 Mar 02;12:617523
pubmed: 33737910
Gynecol Endocrinol. 2017 Aug;33(8):644-648
pubmed: 28393651
Mayo Clin Proc. 2018 Jan;93(1):113-120
pubmed: 29304915
Ann Clin Biochem. 2010 Jul;47(Pt 4):386-9
pubmed: 20511373
Fertil Steril. 2014 Jun;101(6):1766-72.e1
pubmed: 24726216
J Assist Reprod Genet. 2015 Mar;32(3):409-15
pubmed: 25596723
Fertil Steril. 2021 Jan;115(1):54-61
pubmed: 33309062
Arch Pathol Lab Med. 2020 Oct 1;144(10):1193-1198
pubmed: 33002154
Genet Med. 2018 Dec;20(12):1515-1521
pubmed: 29565420
Fertil Steril. 2021 Apr;115(4):922-929
pubmed: 33423785

Auteurs

Frank Z Stanczyk (FZ)

Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California.

Rachel S Mandelbaum (RS)

Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California.

Rogerio A Lobo (RA)

Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York.

Classifications MeSH